US Stock MarketDetailed Quotes

CARM Carisma Therapeutics

Watchlist

1.640
+0.040+2.50%

Trading May 3 09:30 ET

68.13MMarket Cap-766P/E (TTM)

Carisma Therapeutics Stock Forum

Trader Kim

Apr 19 20:55

$Carisma Therapeutics(CARM.US)$ is this a good stock?

NASSER09

Apr 19 02:38

$iSpecimen(ISPC.US)$ sell
$Carisma Therapeutics(CARM.US)$ buy 🏆🔥💴

NASSER09

Apr 19 02:38

$Carisma Therapeutics(CARM.US)$ buy🏆🔥🔥🔥🔥

Moomoo AI

Feb 1 18:40

Carisma Therapeutics' low P/S ratio may be due to limited future growth expectations. Its underwhelming revenue outlook contributes to this low P/S, making a significant share price rise unlikely soon.

Lacklustre Performance Is Driving Carisma Therapeutics, Inc.'s (NASDAQ:CARM) 26% Price Drop

Trytosaveabit

Dec 14, 2023 20:48

News

$Carisma Therapeutics(CARM.US)$ Carisma Therapeutics Has Nominated Its First Lead Candidate Under The Collaboration With Moderna That Will Target An Antigen Present On A Solid Tumor

Whitetea

Nov 29, 2023 10:30

$Carisma Therapeutics(CARM.US)$
FDA news but dipping ?

Alvinnnnnnngenius

Nov 28, 2023 20:02

FDA

$Carisma Therapeutics(CARM.US)$

Moomoo AI

Nov 12, 2023 20:20

Concerns are rising for Carisma Therapeutics following a downgrade as growth expectations fall behind wider market. This could trigger further cuts if the industry deteriorates. Analysts currently bear a grim outlook.